AA
ITCI
AlphaCentric Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20,000
| Closed | -$1.46M | – | 291 |
|
|
2024
Q3 | $1.46M | Hold |
20,000
| – | – | 1.09% | 28 |
|
|
2024
Q2 | $1.37M | Hold |
20,000
| – | – | 1.01% | 30 |
|
|
2024
Q1 | $1.38M | Hold |
20,000
| – | – | 0.83% | 46 |
|
|
2023
Q4 | $1.43M | Sell |
20,000
-5,500
| -22% | -$394K | 0.96% | 36 |
|
|
2023
Q3 | $1.33M | Hold |
25,500
| – | – | 0.75% | 42 |
|
|
2023
Q2 | $1.61M | Hold |
25,500
| – | – | 0.9% | 41 |
|
|
2023
Q1 | $1.38M | Buy |
25,500
+18,000
| +240% | +$975K | 0.95% | 29 |
|
|
2022
Q4 | $397K | Buy |
+7,500
| New | +$397K | 0.39% | 83 |
|
|
2021
Q4 | – | Sell |
-4,000
| Closed | -$149K | – | 280 |
|
|
2021
Q3 | $149K | Sell |
4,000
-1,000
| -20% | -$37.3K | 0.04% | 137 |
|
|
2021
Q2 | $204K | Sell |
5,000
-2,000
| -29% | -$81.6K | 0.06% | 106 |
|
|
2021
Q1 | $238K | Sell |
7,000
-1,000
| -13% | -$34K | 0.08% | 84 |
|
|
2020
Q4 | $254K | Buy |
8,000
+7,450
| +1,355% | +$237K | 0.11% | 53 |
|
|
2020
Q3 | $14K | Buy |
+550
| New | +$14K | 0.01% | 151 |
|